...
首页> 外文期刊>European journal of emergency medicine: Official journal of the European Society for Emergency Medicine >Noninvasive mechanical ventilation in patients with chronic obstructive pulmonary disease and severe hypercapnic neurological deterioration in the emergency room.
【24h】

Noninvasive mechanical ventilation in patients with chronic obstructive pulmonary disease and severe hypercapnic neurological deterioration in the emergency room.

机译:慢性阻塞性肺疾病和急诊室严重高碳酸血症性神经系统恶化的患者的无创机械通气。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: The objective of this study was to assess the effectiveness of noninvasive motion ventilation (NIMV) in patients with chronic obstructive pulmonary disease (COPD), having infectious exacerbation and severe hypercapnic neurological dysfunction in the emergency room. DESIGN: This is a prospective interventional study. SETTING: The study setting was the emergency room at the Military Hospital in Guayaquil, Ecuador. PATIENTS: A total of 24 patients were studied. Twelve patients had acute exacerbation of their chronic obstructive pulmonary disease: they presented at the emergency room with severe neurological dysfunction, with a Glasgow Coma Scale (GCS) score of less than 8 and a pH of less than 7.25. These patients were compared with 12 controls who were being treated with invasive mechanical ventilation (IMV), who were then matched according to their GCS scores, pH status, Acute Physiology and Chronic Health Evaluation II (APACHE II) scores, and age. INTERVENTIONS: We evaluated the effectiveness and safety of applying a ventilatory strategy based on a biphasic positive airway pressure protocol in the emergency room. MEASUREMENTS AND RESULTS: The pH, PCO2, and GCS scores, measured during the first 3 h, were predictors of success for the application of NIMV treatment (P<0.05). Mortality was 33.3 and 16.7% for the IMV and the NIMV groups, respectively (P=0.01). Days of IMV were 5.60+/-1.2 versus 3.6+/-1.1 for NIMV (P=0.006). Days of hospitalization were 11.1+/-4.7 for the IMV group and 6.5+/-1.9 for the NIMV group (P=0.001). The cumulative survival rates at 6 months were 71.4 and 80% for the IMV and NIMV groups, respectively (P=0.80). CONCLUSION: We consider that severe neurological dysfunction and pH of less than 7.25 do not constitute absolute contraindications to the use of NIMV. This kind of management can be implemented in the emergency room with favorable results.
机译:目的:本研究的目的是评估无创运动通气(NIMV)在急诊室中感染性加重和严重高碳酸血症性神经功能障碍的慢性阻塞性肺疾病(COPD)患者的有效性。设计:这是一项前瞻性干预研究。地点:研究地点是厄瓜多尔瓜亚基尔军事医院的急诊室。患者:共研究了24例患者。 12例患者的慢性阻塞性肺疾病急性加重:他们出现在急诊室,伴有严重的神经功能障碍,格拉斯哥昏迷评分(GCS)评分低于8,pH低于7.25。将这些患者与接受有创机械通气(IMV)治疗的12名对照进行比较,然后根据他们的GCS评分,pH值状态,急性生理和慢性健康评估II(APACHE II)得分和年龄进行匹配。干预措施:我们评估了在急诊室基于双相气道正压通气方案实施通气策略的有效性和安全性。测量和结果:在开始的3 h内测得的pH,PCO2和GCS评分是应用NIMV治疗成功的预测指标(P <0.05)。 IMV和NIMV组的死亡率分别为33.3和16.7%(P = 0.01)。 IMV的天数为5.60 +/- 1.2,而NIMV的天数为3.6 +/- 1.1(P = 0.006)。 IMV组住院天数为11.1 +/- 4.7,NIMV组为6.5 +/- 1.9(P = 0.001)。 IMV和NIMV组在6个月时的累积生存率分别为71.4和80%(P = 0.80)。结论:我们认为严重的神经功能障碍和pH值小于7.25并不构成使用NIMV的绝对禁忌症。可以在急诊室实施这种管理,并且效果良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号